| Orders | Qty | Bid |
|---|---|---|
| 1 | 1 | 785.95 |
| 6 | 71 | 785.9 |
| 4 | 17 | 785.85 |
| 1 | 1 | 785.8 |
| 3 | 6 | 785.75 |
| Ask | Qty | Orders |
|---|---|---|
| 786.25 | 2 | 20 |
| 786.7 | 1 | 8 |
| 786.75 | 2 | 8 |
| 786.85 | 2 | 5 |
| 786.95 | 5 | 32 |

Alembic Pharmaceuticals Ltd has delivered -14.50% return over the last 52 weeks. During this period, the stock hit a 52-week high of ₹998.00 on 04 Nov 2025 and a 52-week low of ₹635.80 on 23 Mar 2026. It is currently trading at ₹781.30 as of 22 Oct 2026.
The all-time high (ATH) for Alembic Pharmaceuticals Ltd was ₹1,247.70, recorded on 11 Sep 2024. At the current price of ₹781.30, the stock is trading 37.38% below its all-time high. The all-time low recorded was ₹35.05 on 02 Jan 2012.
Alembic Pharmaceuticals Ltd has delivered a 2.63% absolute return over the past 5 years, equivalent to a CAGR of 0.52% per annum. The stock was priced at ₹761.28 in Oct 2021 and has risen to ₹781.30 as of 22 Oct 2026. An investment of ₹1,00,000 in Alembic Pharmaceuticals Ltd five years ago would be worth ₹1,02,630.00 today.
Yes,Alembic Pharmaceuticals Ltd has declared a consistent dividend every year over the past 5 years. The company paid a total dividend of 62.00 per share between FY2022 and FY2026, with the most recent dividend of ₹12.00 per share for May 26, with an ex-dividend date of 29 Jul 2026. At the current market price of ₹781.30, the trailing dividend yield of Alembic Pharmaceuticals Ltd stands at 23.00%.
Over the last 6 months, Alembic Pharmaceuticals Ltd has given a return of 3.05%. The stock was priced at ₹764.60 on 22 Apr 2026 and has Rise to ₹781.30 as of 22 Oct 2026, a change of ₹16.70 per share.
As of 22 Oct 2026, the share price of Alembic Pharmaceuticals Ltd is ₹781.30 on the NSE and ₹779.00 on the BSE. The stock opened at ₹790.05, touched a high of ₹786.95 and a low of ₹777.15 during today's session.
Alembic Pharmaceuticals Ltd has delivered a return of -2.99% over the last 3 months. The stock was trading at ₹812.20 on 22 Jul 2026 and is currently at ₹781.30 as of 22 Oct 2026, reflecting a Loss of ₹30.90 per share over this period.
The intraday high for Alembic Pharmaceuticals Ltd on the NSE today (22 Oct 2026) was ₹786.95. This compares to the 52-week high of ₹998.00 recorded on 04 Nov 2025. Today's high was -21.15% below the 52-week high.
For Q1 FY27, Alembic Pharmaceuticals Ltd reported: Revenue (Net Sales): ₹18680.60 Cr - Up 8.69% year-on-year from ₹17187.40 Cr in Q4 FY26. Net Income (PAT): ₹1969.60 Cr - Down -18.97% year-on-year from ₹2430.70 Cr in Q4 FY26.
The intraday low for Alembic Pharmaceuticals Ltd on the NSE today was ₹777.15. The stock's 52-week low stands at ₹635.80, recorded on 23 Mar 2026. Today's low is 22.23% above the 52-week low, indicating the stock is trading well above its yearly lows.